daunorubicin has been researched along with Retinal Detachment in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 8 (61.54) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiquet, C; Rouberol, F | 1 |
| Lee, CS; Lee, SC; Shim, JW; Yoon, JS | 1 |
| Choudhary, I; Kumar, A; Nainiwal, S; Tewari, HK; Verma, LK | 1 |
| Ciechanowski, C; Gebka, A; Iwaszkiewicz-Bilikiewicz, B; Raczyńska, K | 1 |
| Kirmani, M; Ryan, SJ; Santana, M; Sorgente, N; Wiedemann, P | 1 |
| Borhani, H; el-Sayed, SH; Fernandes, ML; Luo, Q; Peyman, GA; Rahimy, MH | 1 |
| Bathwal, DP; Khosla, PK; Kumar, A; Tewari, HK | 1 |
| Cai, YS; Heimann, K; Hui, YN; Kirchhof, B; Liang, HC | 1 |
| Hu, D; Hui, YN | 1 |
| Chen, EP; Hatchell, DL; Saloupis, PT; Samsa, GP; Steinhorst, UH | 1 |
| Hatchell, DL; Khawly, JA; Machemer, R; Saloupis, P | 1 |
| Heimann, K; Hilgers, RD; Leinung, C; Wiedemann, P | 1 |
| Gerke, E; Hermeking, H | 1 |
1 review(s) available for daunorubicin and Retinal Detachment
| Article | Year |
|---|---|
[Proliferative vitreoretinopathy: prophylactic treatment].
Topics: Antibiotics, Antineoplastic; Colchicine; Daunorubicin; Fibrinolytic Agents; Fluorouracil; Glucocorticoids; Heparin; Humans; Immunosuppressive Agents; Intravitreal Injections; Keratolytic Agents; Retinal Detachment; Tretinoin; Tubulin Modulators; Vitreoretinopathy, Proliferative | 2014 |
3 trial(s) available for daunorubicin and Retinal Detachment
| Article | Year |
|---|---|
Role of daunorubicin in inhibiting proliferative vitreoretinopathy after retinal detachment surgery.
Topics: Antibiotics, Antineoplastic; Daunorubicin; Female; Humans; Injections; Male; Middle Aged; Retinal Detachment; Scleral Buckling; Visual Acuity; Vitrectomy; Vitreoretinopathy, Proliferative; Vitreous Body | 2002 |
[Vitrectomy with daunorubicin].
Topics: Adult; Daunorubicin; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Retinal Detachment; Retinal Perforations; Secondary Prevention; Treatment Outcome; Vitrectomy; Vitreoretinopathy, Proliferative | 2004 |
[Daunomycin in vitrectomy of complicated diabetic retinal detachment].
Topics: Adult; Aged; Combined Modality Therapy; Daunorubicin; Diabetic Retinopathy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retinal Detachment; Retinal Neovascularization; Vitrectomy | 1990 |
9 other study(ies) available for daunorubicin and Retinal Detachment
| Article | Year |
|---|---|
Acute lymphoblastic leukemia presenting as bilateral serous macular detachment and lacrimal gland enlargement.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Coloring Agents; Daunorubicin; Eye Neoplasms; Female; Fluorescein Angiography; Humans; Hypertrophy; Indocyanine Green; Lacrimal Apparatus; Lacrimal Apparatus Diseases; Leukocyte Count; Magnetic Resonance Imaging; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Retinal Detachment; Tomography, Optical Coherence; Vincristine; Visual Acuity | 2012 |
Control of experimental massive periretinal proliferation by daunomycin: dose-response relation.
Topics: Animals; Cell Division; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Rabbits; Retina; Retinal Detachment | 1983 |
Effects of an intravitreal daunomycin implant on experimental proliferative vitreoretinopathy: simultaneous pharmacokinetic and pharmacodynamic evaluations.
Topics: Animals; Biological Availability; Cell Division; Cells, Cultured; Daunorubicin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Carriers; Drug Implants; Fluorophotometry; Pigment Epithelium of Eye; Rabbits; Random Allocation; Retinal Detachment; Time Factors; Vitreoretinopathy, Proliferative; Vitreous Body | 1994 |
Experimental inhibition of proliferative vitreoretinopathy in retinal detachment using daunorubicin.
Topics: Animals; Cell Division; Daunorubicin; Electroretinography; Fibroblasts; Fundus Oculi; Half-Life; Rabbits; Retina; Retinal Detachment; Vitreoretinopathy, Proliferative | 1994 |
Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Carriers; Eye Diseases; Female; Injections; Liposomes; Macrophages; Male; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1993 |
Prevention of experimental proliferative vitreoretinopathy with daunomycin and triamcinolone based on the time course of the disease.
Topics: Animals; Autoradiography; Cell Division; Daunorubicin; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Female; Inflammation; Macrophages; Male; Rabbits; Retinal Detachment; Triamcinolone; Vitreoretinopathy, Proliferative | 1999 |
The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Daunorubicin; Disease Models, Animal; Drug Therapy, Combination; Eye Diseases; Female; Fibroblasts; Fundus Oculi; Male; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Triamcinolone Acetonide; Vitreous Body | 1992 |
Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.
Topics: Animals; Cell Division; Daunorubicin; Disease Models, Animal; Drug Administration Schedule; Eye Diseases; Fibroblasts; Rabbits; Random Allocation; Retinal Detachment; Retinal Diseases; Vitreous Body | 1991 |
Daunomycin and silicone oil for the treatment of proliferative vitreoretinopathy.
Topics: Daunorubicin; Eye Diseases; Follow-Up Studies; Humans; Longitudinal Studies; Reoperation; Retinal Detachment; Retinal Diseases; Silicone Oils; Visual Acuity; Vitrectomy; Vitreous Body | 1991 |